-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FxP04p7w3Wk37sHvnA+D8ik/ComPJPrxaj/YBoxuCJeYoIlkm2F5/NYDcG9+Op+G RSRO02SoG9d6HsQ4isHUrw== 0000810084-09-000008.txt : 20090202 0000810084-09-000008.hdr.sgml : 20090202 20090202205457 ACCESSION NUMBER: 0000810084-09-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090130 FILED AS OF DATE: 20090202 DATE AS OF CHANGE: 20090202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000810084 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 931099680 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 BUSINESS PHONE: 5036928001 MAIL ADDRESS: STREET 1: 20245 SW 95TH AVENUE CITY: TUALATIN STATE: OR ZIP: 97062 FORMER COMPANY: FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARRELL CHRISTINE CENTRAL INDEX KEY: 0001200160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15360 FILM NUMBER: 09562893 BUSINESS ADDRESS: STREET 1: 211 SOMERVILLE RD 202N CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 9087192244 MAIL ADDRESS: STREET 1: 8405 B SW CURRY DR CITY: WILSONVILLE STATE: OR ZIP: 97070 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-01-30 0 0000810084 BIOJECT MEDICAL TECHNOLOGIES INC BJCT 0001200160 FARRELL CHRISTINE 20245 SW 95TH AVENUE TUALATIN OR 97062 0 1 0 0 VP of Finance BJCT Common Stock 2009-01-30 4 M 0 75000 0 A 171443 D BJCT Common Stock 41447 I 401K Restricted Stock Unit 2009-01-30 4 M 0 75000 0 D 2009-01-30 BJCT Common Stock 75000 218796 D Vesting pursuant to Restricted Stock Unit agreement dated January 30, 2008. Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock. No expiration date. Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 64,696, Restricted Stock Unit 143,000. Christine M. Farrell 2009-02-02 -----END PRIVACY-ENHANCED MESSAGE-----